• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗凝治疗下不可回收下腔静脉滤器患者的长期结局。

Long-Term Outcomes in Patients with Not-Retrieval Inferior Vena Cava Filter Under Anticoagulation.

机构信息

Department of Cardiovascular Medicine, Niigata University Graduate School of Medical and Dental Sciences.

Department of Cardiology, Niigata City General Hospital.

出版信息

Int Heart J. 2022;63(2):306-311. doi: 10.1536/ihj.21-814.

DOI:10.1536/ihj.21-814
PMID:35354751
Abstract

Since permanent inferior vena cava (IVC) filters increase deep vein thrombosis (DVT), filter retrieval should be performed as possible. Despite the guideline recommendation, IVC filters are not always retrieved in clinical practice. To date, many patients with not-retrieval IVC filters have been prescribed anticoagulant therapy, but the long-term prognosis, including venous thromboembolism (VTE) and bleeding events, remains unknown. In this study, 195 patients who underwent IVC filter implantation between 2006 and 2017 at 3 institutions in Niigata City have been investigated about their deaths, VTE recurrence, and bleeding events. After peaking 2009, the number of IVC filter implantation gradually decreased. During observational period, there were 158 patients with not-retrieval IVC filters (the overall retrieval rate of 19.0%). The not-retrieval group included significantly older and more patients with cancer compared to the retrieval group. Anticoagulation therapy was continued in 88% of the not-retrieval group. During a mean follow-up of 5.0 years, 6 symptomatic DVT events associated with inadequate control of anticoagulation and 13 bleeding events were observed. A total of 52 patients died and only the presence of cancer was prognostic risk factor. Although long-term anticoagulation therapy may be associated with bleeding events, there were few recurrent VTE under optimal anticoagulation. It is anticipated that even if the IVC filter cannot be retrieved, appropriate anticoagulation is useful for prevention of DVT recurrence despite the risk of bleeding.

摘要

由于永久性下腔静脉(IVC)过滤器会增加深静脉血栓形成(DVT),因此应尽可能进行过滤器取回。尽管有指南建议,但在临床实践中并非总是取回 IVC 过滤器。迄今为止,许多未取回 IVC 过滤器的患者已接受抗凝治疗,但长期预后,包括静脉血栓栓塞(VTE)和出血事件,仍不清楚。在这项研究中,对 2006 年至 2017 年在新泻市的 3 家机构植入 IVC 过滤器的 195 名患者的死亡、VTE 复发和出血事件进行了调查。2009 年达到峰值后,IVC 过滤器植入数量逐渐减少。在观察期间,有 158 名患者未取回 IVC 过滤器(总取回率为 19.0%)。与取回组相比,未取回组患者年龄明显较大,且癌症患者较多。88%的未取回组继续进行抗凝治疗。在平均 5.0 年的随访期间,观察到 6 例与抗凝控制不足相关的有症状 DVT 事件和 13 例出血事件。共有 52 名患者死亡,只有癌症的存在是预后危险因素。尽管长期抗凝治疗可能与出血事件相关,但在最佳抗凝下,VTE 复发很少。即使无法取回 IVC 过滤器,适当的抗凝也有助于预防 DVT 复发,尽管存在出血风险。

相似文献

1
Long-Term Outcomes in Patients with Not-Retrieval Inferior Vena Cava Filter Under Anticoagulation.抗凝治疗下不可回收下腔静脉滤器患者的长期结局。
Int Heart J. 2022;63(2):306-311. doi: 10.1536/ihj.21-814.
2
Venous thromboembolism after removal of retrievable inferior vena cava filters.可回收下腔静脉滤器取出术后的静脉血栓栓塞症。
Cardiovasc Intervent Radiol. 2010 Feb;33(1):74-9. doi: 10.1007/s00270-009-9682-8. Epub 2009 Sep 19.
3
Indications, applications, and outcomes of inferior vena cava filters for venous thromboembolism in Japanese patients.日本患者下肢静脉血栓形成的下腔静脉滤器的适应症、应用及结果
Heart Vessels. 2016 Jul;31(7):1084-90. doi: 10.1007/s00380-015-0709-6. Epub 2015 Jul 2.
4
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters Study: Design of a unique safety and effectiveness study of inferior vena cava filters in clinical practice.下腔静脉滤器安全性和有效性预测研究:一项独特的下腔静脉滤器在临床实践中的安全性和有效性研究的设计。
J Vasc Surg Venous Lymphat Disord. 2020 Mar;8(2):187-194.e1. doi: 10.1016/j.jvsv.2019.07.009. Epub 2019 Oct 18.
5
Increased incidence of venous thromboembolism associated with inferior vena cava filter placement in patients diagnosed with isolated calf deep vein thrombosis after intracranial hemorrhage or intracranial operation.颅内出血或颅内手术后被诊断为单纯小腿深静脉血栓形成的患者,下腔静脉滤器置入与静脉血栓栓塞发生率增加相关。
J Thromb Thrombolysis. 2023 Feb;55(2):297-303. doi: 10.1007/s11239-022-02736-z. Epub 2022 Dec 16.
6
Role of prophylactic temporary inferior vena cava filters placed at the ICU bedside under intravascular ultrasound guidance in patients with multiple trauma.在血管内超声引导下于重症监护病房床边放置预防性临时下腔静脉滤器在多发伤患者中的作用。
J Vasc Surg. 2004 Nov;40(5):958-64. doi: 10.1016/j.jvs.2004.07.048.
7
Outcomes after inferior vena cava filter placement in cancer patients diagnosed with pulmonary embolism: risk for recurrent venous thromboembolism.癌症合并肺栓塞患者行下腔静脉滤器置入术后的结局:复发性静脉血栓栓塞风险。
J Thromb Thrombolysis. 2017 Nov;44(4):489-493. doi: 10.1007/s11239-017-1557-2.
8
Venous thromboembolism after retrieval of inferior vena cava filters.下腔静脉滤器取出术后的静脉血栓栓塞
J Vasc Interv Radiol. 2008 Apr;19(4):504-508. doi: 10.1016/j.jvir.2007.11.016.
9
Utilization Practices of Inferior Vena Cava Filters at an Academic Medical Center.一家学术医疗中心下腔静脉滤器的使用情况
Cureus. 2024 Mar 4;16(3):e55505. doi: 10.7759/cureus.55505. eCollection 2024 Mar.
10
An expert spotlight on inferior vena cava filters.下腔静脉滤器的专家聚焦
Expert Rev Hematol. 2021 Jul;14(7):593-605. doi: 10.1080/17474086.2021.1943350. Epub 2021 Jun 23.

引用本文的文献

1
Oral Rivaroxaban Versus Warfarin After inferior Vena cava Filter Implantation: A Retrospective Cohort Study.下腔静脉滤器植入术后口服利伐沙班与华法林的比较:一项回顾性队列研究。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241256938. doi: 10.1177/10760296241256938.